Khaghanizadeh, Morteza
Koohi, Aliakbar
Ebadi, Abbas
Vahedian-Azimi, Amir
Article History
Received: 28 May 2022
Accepted: 25 July 2023
First Online: 4 August 2023
Declarations
:
: The authors declare no competing interests.
: <b>Ethics approval and consent to participate</b>.
: The present study was approved by the Ethics Committee of Baqiyatallah University of Medical Sciences, Tehran, Iran, under code IR.BMSU.REC.1394.145. This clinical trial study was registered in Iranian Registry of Clinical Trials under code (IRCT2015122116163N5) in 02/07/2016. Written informed consent was obtained from all participants. This study was performed and reported in accordance with the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) statement and the Declaration of Helsinki of the World Medical Association.
: <b>Consent for publication</b>.
: Not applicable.